Recent advances on thermosensitive and pH-sensitive liposomes employed in controlled release.


Journal

Journal of controlled release : official journal of the Controlled Release Society
ISSN: 1873-4995
Titre abrégé: J Control Release
Pays: Netherlands
ID NLM: 8607908

Informations de publication

Date de publication:
10 12 2019
Historique:
received: 17 06 2019
revised: 26 09 2019
accepted: 27 09 2019
pubmed: 28 10 2019
medline: 28 10 2020
entrez: 25 10 2019
Statut: ppublish

Résumé

Nanotechnology has recently gained lots of interest in drug delivery due to its potential to improve the therapeutic outcomes of various diseases. Particularly, a wide range of different nano-sized vesicles has been investigated for drug delivery. Among them, one of the most attractive and well-investigated nanocarriers are liposomes. Although liposomes have several advantages such as low toxicity, biodegradability and biocompatibility as well as accumulate in tumor site via enhanced permeability and retention (EPR) effect, inefficient drug delivery to the target cells could affect the therapeutic purpose of most of conventional liposomal formulations. Therefore, new systems of drug release including stimuli-responsive liposomal have been introduced for the improvement of the efficacy and release payloads in a site-specific manner. Stimuli-responsive liposomes stay stable in blood stream circulation but are activated in response to internal or external stimuli. This review highlights the development of thermosensitive and pH-sensitive liposomes, focusing on liposomal compositions and the effects of the synthetic polymers on their drug release behavior. Furthermore, in vitro and in vivo applications of these formulations will be discussed.

Identifiants

pubmed: 31647978
pii: S0168-3659(19)30561-9
doi: 10.1016/j.jconrel.2019.09.018
pii:
doi:

Substances chimiques

Delayed-Action Preparations 0
Liposomes 0
Polymers 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

1-22

Informations de copyright

Copyright © 2019 Elsevier B.V. All rights reserved.

Auteurs

Marjan Abri Aghdam (M)

Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.

Roya Bagheri (R)

Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.

Jafar Mosafer (J)

Department of Medical Biotechnology, School of Paramedical Science, Torbat Heydariyeh University of Medical Sciences, Torbat Heydariyeh, Iran; Nanotechnology Research center, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran.

Behzad Baradaran (B)

Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.

Mahmoud Hashemzaei (M)

Department of Pharmacodynamics and Toxicology, School of Pharmacy, Zabol University of Medical Sciences, Zabol, Iran.

Amir Baghbanzadeh (A)

Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.

Miguel de la Guardia (M)

Department of Analytical Chemistry, University of Valencia, Dr. Moliner 50, 46100, Burjassot, Valencia, Spain. Electronic address: miguel.delaguardia@uv.es.

Ahad Mokhtarzadeh (A)

Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran; Department of Biotechnology, Higher Education Institute of Rab-Rashid, Tabriz, Iran. Electronic address: mokhtarzadehah@tbzmed.ac.ir.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH